Showing results (121-130 of 153) with videos related to
Sort By:
Pageof 16
Journal of Contemporary Brachytherapy|May 24, 2018
A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomesMichael Chao, Sandra Spencer, Mario Guerrieri, et al.Journal of Medical Imaging and Radiation Sciences|October 6, 2022
Hyaluronic acid rectal spacer in EBRT: Usability, safety and symmetry related to user experienceJack Williams, Kevin Mc Millan, Damien Bolton, et al.Surgical Endoscopy|November 6, 2020
Current status on the adoption of high energy devices in Italy: An Italian Society for Endoscopic Surgery and New Technologies (SICE) national surveyEmanuele Botteri, Mauro Podda, Alberto Arezzo, et al.Journal of Medical Imaging and Radiation Oncology|April 6, 2021
Neoadjuvant radiotherapy for locally advanced and high-risk breast cancerPhoebe Chidley, Farshad Foroudi, Mark Tacey, et al.Oncology Reports|June 7, 2017
Low HtrA1 expression in patients with long‑standing ulcerative colitis and colorectal cancerEmma Altobelli, Giovanni Latella, Manrico Morroni, et al.Annals of Coloproctology|March 9, 2026
Interim analysis of short-term outcomes between robotic and laparoscopic surgery for colon cancer: results from the ESSIMIC trialMarco Milone, Sara Vertaldi, Pietro Anoldo, et al.Updates in Surgery|July 3, 2020
Italian multi-society modified Delphi consensus on the definition and management of anastomotic leakage in colorectal surgeryAntonino Spinelli, Gabriele Anania, Alberto Arezzo, et al.Minerva Surgery|September 14, 2023
Colonic Resection, Stoma, or Self-expanding Metal Stents for Obstructive Left Colon Cancer: the CROSCO-1 study protocolAlessio Giordano, Mauro Podda, Giulia Montori, et al.Annals of Surgical Oncology|December 2, 2021
Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh TrialFrancesco Marchegiani, Valeria Palatucci, Giulia Capelli, et al.BMC Cancer|February 13, 2025
A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocolEric Wegener, Michael Ng, Mario Guerrieri, et al.Pageof 16